M. Morena et al., Why hemodialysis patients are in a prooxidant state? What could be done tocorrect the pro/antioxidant imbalance, BLOOD PURIF, 18(3), 2000, pp. 191-199
Oxidative stress which results from an imbalance between reactive oxygen sp
ecies production and antioxidant defense mechanisms is now well recognized
in hemodialysis (HD) patients and could be involved in dialysis-related pat
hologies such as accelerated atherosclerosis, amyloidosis and anemia. In or
der to evaluate the rationale for preventive intervention against oxidative
damage during HD, we review the factors that are implied and may be respon
sible for the imbalance between pro- and antioxidative mechanisms. The infl
ammatory state mainly due to hemobioincompatibility of the dialysis system
plays a critical role in the production of free oxygen radical species cont
ributing by this way to worsen the prooxidant status of uremic patients. Tw
o factors largely contribute to the stimulation of the NADPH oxidase: hemor
eactivity of the mem bra ne and trace amounts of endotoxins. The antioxidan
t system is severely impaired in uremic patients and gradually altered with
the degree of renal failure. HD could further impair this antioxidant syst
em mainly by losses of (a) hydrophilic unbound small-molecular-weight subst
ances such as vitamin C, (b) trace elements and (c) enzyme-regulatory compo
unds. Two main axes may be proposed in order to prevent and/or to decrease
oxidative stress in HD patients. One consists in improving the hemocompatib
ility of the dialysis system mainly by using a dialyzer with low hemoreacti
vity and ultrapure, sterile, nonpyrogenic dialysate. The other consists in
supplementing the deficiency patients with antioxidants. This could be achi
eved by oral or perdialytic supplementation. Vitamin E could be bound on di
alyzer membrane. Alternatively, hemolipodialysis consists in loading HD pat
ients with vitamin C or E via an ancillary circuit made of vitamin E-rich l
iposomes. The presence of liposomes could also facilitate the removal of hy
drophobic prooxidative substances. Copyright (C) 2000 S. Karger AG. Basel.